UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Bivariate network meta-analysis for surrogate endpoint evaluation

Bujkiewicz, S; Jackson, D; Thompson, JR; Turner, RM; Städler, N; Abrams, KR; White, IR; (2019) Bivariate network meta-analysis for surrogate endpoint evaluation. Statistics in Medicine 10.1002/sim.8187. Green open access

[thumbnail of Turner_Bivariate network meta-analysis for surrogate endpoint evaluation_AOP.pdf]
Preview
Text
Turner_Bivariate network meta-analysis for surrogate endpoint evaluation_AOP.pdf - Published Version

Download (989kB) | Preview

Abstract

Surrogate endpoints are very important in regulatory decision making in healthcare, in particular if they can be measured early compared to the long-term final clinical outcome and act as good predictors of clinical benefit. Bivariate meta-analysis methods can be used to evaluate surrogate endpoints and to predict the treatment effect on the final outcome from the treatment effect measured on a surrogate endpoint. However, candidate surrogate endpoints are often imperfect, and the level of association between the treatment effects on the surrogate and final outcomes may vary between treatments. This imposes a limitation on methods which do not differentiate between the treatments. We develop bivariate network meta-analysis (bvNMA) methods, which combine data on treatment effects on the surrogate and final outcomes, from trials investigating multiple treatment contrasts. The bvNMA methods estimate the effects on both outcomes for all treatment contrasts individually in a single analysis. At the same time, they allow us to model the trial-level surrogacy patterns within each treatment contrast and treatment-level surrogacy, thus enabling predictions of the treatment effect on the final outcome either for a new study in a new population or for a new treatment. Modelling assumptions about the between-studies heterogeneity and the network consistency, and their impact on predictions, are investigated using an illustrative example in advanced colorectal cancer and in a simulation study. When the strength of the surrogate relationships varies across treatment contrasts, bvNMA has the advantage of identifying treatment comparisons for which surrogacy holds, thus leading to better predictions.

Type: Article
Title: Bivariate network meta-analysis for surrogate endpoint evaluation
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/sim.8187
Publisher version: https://doi.org/10.1002/sim.8187
Language: English
Additional information: This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
Keywords: Bayesian analysis, multivariate meta-analysis, network meta-analysis, surrogate endpoints
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL
URI: https://discovery.ucl.ac.uk/id/eprint/10075070
Downloads since deposit
97Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item